Objectives: This study determined the test performance of dobutamine stress echocardiography (DSE) in end-stage liver disease (ESLD).
Background: The reported sensitivity of DSE in ESLD has been variable.
Methods: Data from 633 ESLD patients who had coronary angiography within 6 months after DSE was analyzed.